Cytokinetics (CYTK), Incorporated announced the launch of “On Track with HCM,” demonstrating the company’s long-standing commitment to the, Hypertrophic Cardiomyopathy, HCM community. The campaign features four-time Olympic gold medalist Sydney McLaughlin-Levrone, and her father, three-time all-American track star, Willie McLaughlin, who suffered from the non-obstructive form of hypertrophic cardiomyopathy, HCM, for more than two decades before receiving a heart transplant.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYTK:
- Cytokinetics announces Myqorzo available in U.S.
- Cytokinetics price target raised to $108 from $90 at B. Riley
- 3 ‘Strong Buy’ Stocks to Buy Today, 1/14/2026, According to Top Analysts
- Cytokinetics price target raised to $90 from $71 at Morgan Stanley
- Tango Therapeutics appoints Sung Lee to board of directors